BioMatrix buys LUX Infusion, expands its home infusion nursing capabilities
By HME News Staff
Updated 9:15 AM CST, Thu November 13, 2025
PLANTATION, Fla. – BioMatrix Infusion Pharmacy has acquired LUX Infusion, an ambulatory infusion center business in Alaska, Paragon Ventures has announced. LUX operates three state-of-the-art infusion centers across the state. “Our decision to acquire LUX Infusion is rooted in a shared commitment to advancing access, quality, and innovation in ambulatory infusion care,” said Ted Kramm, CEO, BioMatrix Infusion Pharmacy. “Together, we are better positioned to transform infusion care delivery and ensure that patients nationwide receive the highest standard of treatment.” Through the integration of LUX Infusion, BioMatrix strengthens its national platform in several key ways, including:
-
Integrates LUX’s highly skilled care teams and proven operating model into BioMatrix’s growing nationwide network.
-
Combines resources to scale new infusion sites more efficiently and deliver expanded therapy options.
-
Extends BioMatrix’s home infusion nursing capabilities into the Pacific Northwest, providing greater flexibility and access for patients who prefer care in the home setting.
LUX Infusion recently received NICA accreditation and the designation of AICE-Ambulatory Infusion Center of Excellence, reflecting its commitment to delivering safe, high-quality and value-based infusion care, the company says.
Comments